popular wires

Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market.

As older Australians look for affordable housing, Aspen’s smart model provides both shelter and shareholder value.

Institutional demand has been fuelling Bitcoin’s comeback, potentially shifting crypto from speculation to strategic investment.

Rising inequality is distorting markets, powering US exceptionalism, and setting the stage for potential volatility ahead.

The June CPI report came in as expected, bringing the annual headline increase to 2.7%, a tick-up from last month’s 2.4% reading. Meanwhile, core inflation rose 2.9%,...

It was the old-world store of value and the new-age digital gold that stole the show in FY25.

Bloomberg is talking a once-in-a-generation copper trade. Get ready to be sold to! Traders want you to take the other side of this trade.

We unpack six key themes that stood out from over 30 meetings with prospective and existing investees across Europe, the UK and the US.

The RBA’s proposed surcharge ban and fee caps may reshape payments, but Visa and Mastercard are already positioned for the shift.

While markets chase the AI hype, medtech quietly trades at decade-lows. Here’s why that’s an opportunity for long-term patient investors.

Explore U.S. economic trends: growth uncertainty and rising inflation risks.

In this series, we're profiling managers whose funds are constituents of the 20-Year Club (i.e. at least two decades of operation).

These days, it’s widely recognised that nuclear power will be a critical component of the global transition to clean energy. In fact, some might say the theme is “old...

At the current earnings multiple, we believe Amcor provides us with an ample margin of safety.

With the AT1 hybrid market being phased out, investors will be looking for solutions. VanEck has a handful of ETFs that could fill the void.

Global equities are on fire: a sector up 118%, a country ETF up 43%. Here are the markets investors can’t afford to ignore.

Alphabet’s real strength isn’t in its parts, it’s in their integration. Break it up, and the signal powering Google ads deteriorates.

The passage of the so-called “Big Beautiful Bill” will, by itself, boost growth over the medium term. However, offsetting the extent of any boost will be ever-changing...

Auscap’s Will Mumford reveals 2 growth stocks he’s backing in a sector where “discretionary” items are starting to become essential.

In this series, we're profiling managers whose funds are constituents of the 20-year club (i.e. at least two decades of operation).